Assess the effects of TAD/FIN coadministration ( compared with placebo [ PBO ] / FIN ) on erectile and sexual function in sexually active men with LUTS and prostatic enlargement secondary to BPH with or without baseline comorbid erectile dysfunction ( ED ) .